US Broker Ratings

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 25.90% Potential Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, primarily focuses on diagnostics and research. With a market capitalization of $44.2 billion, this..

Bio-Techne Corp (TECH) Stock Analysis: Navigating the Upside Amidst a Strong Market Cap and Innovation in Biotechnology

Bio-Techne Corp (NASDAQ: TECH) stands as a significant player in the biotechnology sector, boasting a robust market cap of $11.38 billion. Headquartered in Minneapolis, Minnesota, Bio-Techne..

Telix Pharmaceuticals Limited (TLX): Investor Outlook on a Biotech with 93.33% Upside Potential

Telix Pharmaceuticals Limited (TLX), a notable player in the biotechnology sector, has captured the attention of investors with its robust product pipeline and significant market position...

Royalty Pharma (RPRX) Stock Analysis: Navigating a 7% Potential Upside in Biopharma Royalties

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biopharmaceutical landscape, not as a developer of therapies but as a strategic investor in the royalties of..

Ionis Pharmaceuticals (IONS) Stock Analysis: Navigating the Road to a Potential 95% Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at a fascinating juncture, presenting both challenges and opportunities for investors navigating the biotech landscape. As a commercial-stage biotech company..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 0.85% Potential Upside Amidst Tough Market Conditions

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, is currently at an intriguing juncture for investors, reflected by its market cap..

Cardinal Health, Inc. (CAH) Stock Analysis: A Healthcare Giant with Room for Growth

Cardinal Health, Inc. (NYSE: CAH), a key player in the healthcare sector, stands out as a compelling investment opportunity. With a market capitalization of $58.83 billion,..

Tenet Healthcare Corporation (THC) Stock Analysis: Evaluating a 7.17% Upside Potential for Investors

Tenet Healthcare Corporation (NYSE: THC), a leading player in the healthcare sector, is drawing attention from investors with a promising 7.17% potential upside, as per recent..

Glaukos Corporation (GKOS) Stock Analysis: Potential 20.91% Upside Fuels Investor Interest in Innovative Ophthalmic Solutions

Glaukos Corporation (NYSE: GKOS), a key player in the healthcare sector specializing in medical devices for ophthalmic treatment, has been capturing investor attention due to its..

Elevance Health, Inc. (ELV) Stock Analysis: Evaluating the Healthcare Giant’s Growth Potential and Market Position

Elevance Health, Inc. (NYSE: ELV), a leading player in the healthcare plans sector, has been navigating the complexities of the healthcare industry with a notable market..

Corcept Therapeutics (CORT) Stock Analysis: Unraveling a 28% Upside Potential in Biotechnology

Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing opportunity for investors with its robust pipeline and significant potential upside. Operating in the dynamic biotechnology sector, Corcept..

Becton, Dickinson and Company (BDX) Investor Outlook: Analyzing a 1.21% Potential Upside in the Healthcare Sector

Becton, Dickinson and Company (NYSE: BDX) stands as a stalwart in the healthcare sector, with a market capitalization of $52.23 billion. With its extensive portfolio of..

Penumbra, Inc. (PEN) Stock Analysis: Navigating Growth in the Medical Device Sector with a 12.99% Upside

Penumbra, Inc. (PEN), a prominent player in the medical devices industry, continues to garner attention from investors looking to capitalize on growth within the healthcare sector...

Solventum Corporation (SOLV) Stock Analysis: Exploring a 10% Potential Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV) has emerged as a noteworthy player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $14.61..

Charles River Laboratories (CRL) Stock Analysis: A Healthcare Giant with a 5.13% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL), a formidable player in the healthcare sector, stands as a pivotal entity in the diagnostics and research industry. With..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating the 9.33% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare industry, continues to capture investor interest with its robust market presence and promising valuation metrics. With..

Stryker Corporation (SYK) Stock Analysis: Strong Buy Ratings and Over 23% Potential Upside

Stryker Corporation (NYSE: SYK), a leader in the medical devices industry, continues to capture investor attention with a robust market cap of $113.02 billion. With its..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Why Analysts See a 40% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, has caught the attention of investors with its robust pipeline and strategic growth initiatives...

ICON plc (ICLR) Stock Analysis: Navigating a 10.33% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leader in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with its significant potential upside...

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 31.55% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector specializing in medical instruments and supplies, has long been a forerunner in the orthodontics..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds